Physician profile
Sandhya Saxena
NPI 1336166990
$1,375.46
in general payments reported to CMS, 2019-2025
16 companies · $16.12 in 2025
The $16.12 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.95 · 2020: $256 · 2021: $479 · 2022: $140 · 2023: $234 · 2024: $180 · 2025: $16.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $308.45 | 2021-2024 | Airsupra, Breztri |
| Novo Nordisk INC | $213.48 | 2020-2023 | |
| Lilly USA, LLC | $194.14 | 2019-2025 | Mounjaro |
| Pfizer INC. | $172.89 | 2020-2024 | |
| Glaxosmithkline, LLC. | $121.65 | 2023 | Arexvy |
| Merck Sharp & Dohme LLC | $100.45 | 2020-2024 | Capvaxive, Gardasil, Gardasil 9 |
| Abbvie INC. | $75.46 | 2021-2023 | Vraylar, Viberzi |
| Mylan Specialty L.P. | $44.90 | 2020-2022 | |
| Amgen INC. | $25.46 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.09 | 2019-2021 | |
| Corcept Therapeutics | $21.41 | 2019 | |
| Abbott Laboratories | $18.19 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $17.91 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.35 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.39 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandhya Saxena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.